Citation: Mj. Millan et A. Gobert, (-)-Pindolol increases dialysate concentrations of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely-moving rats, NEUROPHARM, 38(6), 1999, pp. 909-912
Citation: A. Dekeyne et al., Discriminative stimulus properties of the novel serotonin (5-HT)(2C) receptor agonist, RO 60-0175: a pharmacological analysis, NEUROPHARM, 38(3), 1999, pp. 415-423
Citation: A. Gobert et Mj. Millan, Serotonin (5-HT)(2A) receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats, NEUROPHARM, 38(2), 1999, pp. 315-317
Authors:
Newman-Tancredi, A
Cussac, D
Audinot, V
Millan, MJ
Citation: A. Newman-tancredi et al., Actions of roxindole at recombinant human dopamine D-2, D-3 and D-4 and serotonim 5-HT1A, 5-HT1B and 5-HT1D receptors, N-S ARCH PH, 359(6), 1999, pp. 447-453
Authors:
Cussac, D
Newman-Tancredi, A
Pasteau, V
Millan, MJ
Citation: D. Cussac et al., Human dopamine D-3 receptors mediate mitogen- activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism, MOLEC PHARM, 56(5), 1999, pp. 1025-1030
Authors:
Newman-Tancredi, A
Cussac, D
Audinot, V
Pasteau, V
Gavaudan, S
Millan, MJ
Citation: A. Newman-tancredi et al., G protein activation by human dopamine D-3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5 '-O-(3-[S-35]thio)-triphosphate binding and antibody study, MOLEC PHARM, 55(3), 1999, pp. 564-574
Authors:
Millan, MJ
Schreiber, R
Monneyron, S
Denorme, B
Melon, C
Queriaux, S
Dekeyne, A
Citation: Mj. Millan et al., S-16924, a novel, potential antipsychotic with marked serotonin(1A) agonist properties. IV. A drug discrimination comparison with clozapine, J PHARM EXP, 289(1), 1999, pp. 427-436
Authors:
Millan, MJ
Brocco, M
Gobert, A
Schreiber, R
Dekeyne, A
Citation: Mj. Millan et al., S-16924 [(R)-2-{1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl}1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic withmarked serotonin(1A) agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol, J PHARM EXP, 288(3), 1999, pp. 1002-1014
Authors:
Newman-Tancredi, A
Rivet, JM
Chaput, C
Touzard, M
Verriele, L
Millan, MJ
Citation: A. Newman-tancredi et al., The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [S-35]GTP gamma S and [H-3]S15535 autoradiography study, EUR J PHARM, 384(2-3), 1999, pp. 111-121
Authors:
Millan, MJ
Gobert, A
Girardon, S
Dekeyne, A
Citation: Mj. Millan et al., Citalopram elicits a discriminative stimulus in rats at a dose selectivelyincreasing extracellular levels of serotonin vs. dopamine and noradrenaline, EUR J PHARM, 364(2-3), 1999, pp. 147-150
Authors:
Carli, M
Balducci, C
Millan, MJ
Bonalumi, P
Samanin, R
Citation: M. Carli et al., S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine, BR J PHARM, 128(6), 1999, pp. 1207-1214
Authors:
Sebban, C
Zhang, XQ
Tesolin-Decros, B
Millan, MJ
Spedding, M
Citation: C. Sebban et al., Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission, BR J PHARM, 128(5), 1999, pp. 1045-1054
Authors:
Sebban, C
Tesolin-Decros, B
Millan, MJ
Spedding, M
Citation: C. Sebban et al., Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil, BR J PHARM, 128(5), 1999, pp. 1055-1063